Dermozone looks to expand footprints in India
Indonesia-based Dermozone is all set to revolutionise the wound-healing and skincare market in India with its path-breaking molecule +dalethyne, which was invented after 18 years of research since 2000. The founder of Dermozone, Kayapan Satya Dharshan said: After more than three years of extensive market study and research in India we are all set to launch our +dalethyne based Dermozone wound care range of products which has received overwhelming initial response from hospitals and doctors for the treatment of chronic and acute wounds like diabetic foot ulcers, decubitus ulcer, deep cavity wounds, burns, and post-operative / traumatic wounds,” said Dharshan.
He further said in many cases our wound care products have been lifesaving and also have prevented near certain amputations of patients suffering from Diabetic related wounds. “+dalethyne is a clinically tested compound obtained from artificial segregation of naturally abundant fatty acids in virgin olive oil. It has proven the effect of antimicrobial, fungicidal and antiviral quality with deep skin-penetrable quality. Investigations have revealed that +dalethyne reduces inflammation and accelerates wound healing.”
What makes it so unique?
Wounds are measured in scale from 0-4B. Usually, doctors look at that. So scale from 0-1A-2A-2B can be handled by yourself but from 3A-4B you need doctors to handle it. Efficacy of this product is that it can handle from 04B, depends on time. Everybody has a different way of handling his wounds. Some types of wound remain there for 34 weeks, it depends on the body. Dalethyne can handle acute wounds like surgery wounds and all ordinary wounds which don’t have metabolic disorders. Chronic wounds happen because of metabolic disorders and these are usually heavy which take a longer time to heal. It scales under 3B-4B. This includes all the wounds created because of diabetes, cancer, HIV, kidney patients or any other type of patients with different wounds. So this is the efficacy of this product.
Dalethyne is a new medicine with 15-18 compounds in it. We derived it after changing the compound of fatty acid in the oil and made a new 18 chemistry compound. This new 18 chemistry compound has the ability to kill the germs, to start a new skin and vessels. So the difference is that usually, doctors use a lot of products to cater one wound now they just have to use Dermozone dalethyne to handle this type of situation, sickness and wounds.
What is the role of dalethyne?
Wound care market in India is vast with a lot of brands names. Nowadays there are some antibiotics which could kill germs earlier but unable to kill germs that are growing. They also cannot reach a situation where dalethyne can reach.
What are Dermozone’s future plans?
Out future plan is to expand PAN India and we will try to visit some neighbouring countries too. We will cover the Indian market with the 9 products that we have.